ArticleProceedings of the National Academy of Sciences of the United States of America2015

The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.

Xavier Cullere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.